Dashboard
Manage Tickers

OPRXOptimizeRx Corp

Nasdaq optimizerx.com


$ 13.08 $ 0.39 (3.07 %)    

Monday, 20-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 3.15 (0.7 %)
DIA $ 398.57 $ -1.85 (-0.46 %)
SPY $ 530.36 $ 0.61 (0.12 %)
TLT $ 91.26 $ -0.27 (-0.3 %)
GLD $ 225.37 $ 0.90 (0.4 %)
$ 13.08
$ 12.60
$ 0.00 x 0
$ 0.00 x 0
$ 12.60 - $ 13.31
$ 6.92 - $ 16.65
249,875
na
237.67M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-15-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-10-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-08-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 03-08-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-31-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

gold-rises-over-1-arcos-dorados-shares-fall-after-q1-results
Gold Rises Over 1%; Arcos Dorados Shares F...
05/15/2024 18:33:38

jmp-securities-maintains-market-outperform-on-optimizerx-raises-price-target-to-16
JMP Securities Maintains Market Outperform...
05/15/2024 17:42:04

JMP Securities analyst Constantine Davides maintains OptimizeRx (NASDAQ:OPRX) with a Market Outperform and raises the price ...

why-bolt-biotherapeutics-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bolt Biotherapeutics Shares Are Tradin...
05/15/2024 17:38:38

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/15/2024 16:31:58

nasdaq-surges-150-points-retail-sales-flat-for-april
Nasdaq Surges 150 Points; Retail Sales Fla...
05/15/2024 16:05:39

expert-ratings-for-optimizerx
Expert Ratings For OptimizeRx
05/15/2024 13:00:52

stifel-maintains-buy-on-optimizerx-maintains-13-price-target
Stifel Maintains Buy on OptimizeRx, Mainta...
05/15/2024 11:51:54

Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and maintains $13 price target.

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 20:31:13

optimizerx-reiterates-fy24-guidance-with-revenue-to-be-at-least-100m-est-101313m-adjusted-ebitda-of-at-least-11m
OptimizeRx Reiterates FY24 Guidance With R...
05/14/2024 20:29:42

optimizerx-q1-adj-011-beats-013-estimate-sales-1969m-beat-1813m-estimate
OptimizeRx Q1 Adj $(0.11) Beats $(0.13) Es...
05/14/2024 20:12:34

OptimizeRx (NASDAQ:OPRX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by...

optimizerx-corporation-says-1q24-revenue-expected-to-grow-over-40-yoy-and-come-in-between-185m-192m-vs-1703m-estimate-company-says-daap-adoption-and-cross-selling-activities-are-tracking-ahead-of-internal-expectations
OptimizeRx Corporation Says 1Q24 Revenue E...
04/26/2024 11:37:50

For the first quarter, the Company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $1...

jmp-securities-reiterates-market-outperform-on-optimizerx-maintains-15-price-target
JMP Securities Reiterates Market Outperfor...
04/16/2024 15:18:48

JMP Securities analyst Constantine Davides reiterates OptimizeRx (NASDAQ:OPRX) with a Market Outperform and maintains $15 pr...

optimizerx-sees-fy24-revenue-of-100m-vs-10473m-est
OptimizeRx Sees FY24 Revenue Of $100M Vs. ...
04/16/2024 11:08:14

optimizerx-q4-adj-eps-026-inline-sales-2840m-beat-2647m-estimate
OptimizeRx Q4 Adj EPS $0.26, Inline, Sales...
04/16/2024 11:06:03

OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.26 per share which met the analyst consensus estimate. This...

jmp-securities-initiates-coverage-on-optimizerx-with-market-outperform-rating-announces-price-target-of-15
JMP Securities Initiates Coverage On Optim...
04/04/2024 09:02:53

JMP Securities analyst Constantine Davides initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Market Outperform rating an...

where-optimizerx-stands-with-analysts
Where OptimizeRx Stands With Analysts
04/01/2024 18:00:37

stifel-maintains-buy-on-optimizerx-maintains-13-price-target
Stifel Maintains Buy on OptimizeRx, Mainta...
04/01/2024 15:05:16

Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and maintains $13 price target.

rbc-capital-reiterates-outperform-on-optimizerx-maintains-17-price-target
RBC Capital Reiterates Outperform on Optim...
04/01/2024 13:50:42

RBC Capital analyst Sean Dodge reiterates OptimizeRx (NASDAQ:OPRX) with a Outperform and maintains $17 price target.

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

optimizerx-earnings-preview
OptimizeRx Earnings Preview
03/27/2024 17:01:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION